ArticleCancers2026

Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis.

Sabrina Pelliccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.